Cantharidin Application in Molluscum Patients-1

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This study is a Phase 3, randomized, double-blind, placebo-controlled, pivotal study to evaluate the safety and efficacy of VP-102 topical film-forming solution in subjects with Molluscum Contagiosum. VP-102 will be applied once every 21 days for up to 4 applications, to treatable molluscum contagiosum (molluscum) lesions on subjects 2 years and older. Efficacy will be assessed as the proportion of subjects achieving complete clearance of all treatable molluscum lesions (baseline and new) on the Day 84 visit.
Epistemonikos ID: 087075e851f729252a8cb6b0ad5cf7dd19714f92
First added on: May 21, 2024